aMoon

aMoon is a leading Israeli life sciences venture fund. Our team is passionate about building successful businesses and helping Israeli biopharma, digital health and medical technology companies realize their potential.

Category: News

Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study

Posted on January 31, 2018December 28, 2020Author gilrabbiCategories News

Pharma Two B Ltd. Closes $30 Million Financing Round

Posted on January 23, 2018December 28, 2020Author gilrabbiCategories News

Marius Nacht to invest $20m in Regenera

Posted on January 2, 2018December 28, 2020Author gilrabbiCategories News

Nacht, Harel Insurance invest in personalized cancer treatment

Posted on December 7, 2017December 28, 2020Author gilrabbiCategories News

Ayala Pharmaceuticals, Founded by Israel Biotech Fund, aMoon and Harel Insurance, Enters Exclusive Worldwide License Agreement with Bristol-Myers Squibb (BMS) to Develop Cancer Treatments

Posted on December 6, 2017December 28, 2020Author gilrabbiCategories News

Mapi Pharma Ltd. Announces Closing of $10 Million Investment

Posted on August 17, 2017December 28, 2020Author gilrabbiCategories News

CartiHeal raises $18.3m to support PMA trial of Agili-C implant

Posted on May 8, 2017December 28, 2020Author gilrabbiCategories News

Posts pagination

Previous page Page 1 … Page 14 Page 15
Contact Careers terms of service privacy policy
aMoon on linkedin aMoon on linkedin aMoon on twitter aMoon on twitter aMoon on youtube aMoon on youtube
Ra'anana, Israel
© aMoon Website by nym. Developed by Rabbi Interactive